{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:06:04Z","timestamp":1785942364231,"version":"3.56.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Suzhou Applied Basic Research Technology Innovation Project","award":["SYWD2024076"],"award-info":[{"award-number":["SYWD2024076"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,17]]},"abstract":"<jats:p>\n                    This study aims to investigate the potential impact of nonalcoholic fatty liver disease (NAFLD) on the risk or severity of community-acquired pneumonia (CAP) in children and adolescents aged 6 to 17 years. Non-contrast chest computed tomography (CT) scans and laboratory data from patients aged 6 to 17 years with respiratory symptoms or fever between July and December 2023 were retrospectively analyzed. NAFLD and its severity were diagnosed based on a liver-spleen CT value ratio. The incidence and distribution of NAFLD across each age group were calculated. Abdominal circumference was measured using CT with specialized software. Chest CT scores quantified the severity of CAP, while inflammatory indices assessed positive C-reactive protein levels and white blood cell counts. Patients with NAFLD were assigned to the observation group, with non-NAFLD patients matched by age and sex served as the control group in a 1:1 ratio. One-way analysis of variance and independent sample rank-sum tests were used to analyze differences in chest CT scores, abdominal circumference, and inflammatory indices. Among 4740 eligible cases, the incidence of NAFLD increased with age, with an overall rate of 5.30%, and was more common in boys. The NAFLD group showed significantly higher abdominal circumference and inflammatory indices than those of the non-NAFLD group (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). There were no significant intergroup differences in chest CT scores or sex (all\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05). The chest CT score, proportion of males, and abdominal circumference were significantly higher in the moderate-to-severe NAFLD group than that in the mild NAFLD group (all\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). No significant intergroup differences were observed in age or inflammatory indices (all\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05). Patients with moderate-to-severe NAFLD had higher chest CT scores than those with mild NAFLD. Moderate-to-severe NAFLD was associated with an increased risk or severity of CAP in children and adolescents aged 6 to 17 years.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048414","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:02:44Z","timestamp":1776434564000},"page":"e48414","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Impact of nonalcoholic fatty liver disease severity on community-acquired pneumonia in children and adolescents aged 6 to 17 years: A retrospective CT-based study"],"prefix":"10.1097","volume":"105","author":[{"given":"Hanwen","family":"Shi","sequence":"first","affiliation":[{"name":"Department of Radiology, Kunshan Integrated TCM and Western Medicine Hospital, Kunshan, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilin","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kunshan Hospital of Chinese Medicine, Kunshan, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kunshan Hospital of Chinese Medicine, Kunshan, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchun","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kunshan Hospital of Chinese Medicine, Kunshan, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kunshan Integrated TCM and Western Medicine Hospital, Kunshan, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8379-5317","authenticated-orcid":false,"given":"Juntao","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kunshan Hospital of Chinese Medicine, Kunshan, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260605","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement.","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"R2-20260605","first-page":"e18201","article-title":"Decoding the pathophysiology of non-alcoholic fatty liver disease progressing to non-alcoholic steatohepatitis: a systematic review.","volume":"13","author":"Yaqub","year":"2021","journal-title":"Cureus"},{"key":"R3-20260605","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","article-title":"NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert committee on NAFLD (ECON) and the North American society of pediatric gastroenterology, hepatology and nutrition (NASPGHAN).","volume":"64","author":"Vos","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R4-20260605","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).","volume":"81","year":"2024","journal-title":"J Hepatol"},{"issue":"6S Suppl 1","key":"R5-20260605","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/INF.0000000000002318","article-title":"Biomarkers for Infection in children: current clinical practice and future perspectives.","volume":"38","author":"Stol","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"R6-20260605","first-page":"2052","article-title":"The role of non-alcoholic fatty liver disease in infections.","volume":"12","author":"Krznari\u0107","year":"2022","journal-title":"Life (Basel)"},{"key":"R7-20260605","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","article-title":"American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the american association for the study of liver diseases (AASLD).","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocrine Pract"},{"key":"R8-20260605","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3349\/ymj.2022.0540","article-title":"Changes in the prevalences of obesity, abdominal obesity, and non-alcoholic fatty liver disease among korean children during the COVID-19 outbreak.","volume":"64","author":"Song","year":"2023","journal-title":"Yonsei Med J"},{"key":"R9-20260605","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s12519-024-00814-1","article-title":"Prevalence of nonalcoholic fatty liver disease in pediatrics and adolescents: a systematic review and meta-analysis.","volume":"20","author":"Lee","year":"2024","journal-title":"World J Pediatr"},{"key":"R10-20260605","first-page":"748","article-title":"Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association; National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver and Metabolism, Chinese Society of Endocrinology, Chinese Medical Association..","volume":"27","year":"2019","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"R11-20260605","first-page":"198","article-title":"Association between non-alcoholic fatty liver disease and hospitalized patients with community-acquired pneumonia.","volume":"19","author":"Nseir","year":"2017","journal-title":"Isr Med Assoc J"},{"key":"R12-20260605","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/qjmed\/hcy227","article-title":"Non-alcoholic fatty liver disease and 30-day all-cause mortality in adult patients with community-acquired pneumonia.","volume":"112","author":"Nseir","year":"2019","journal-title":"QJM"},{"key":"R13-20260605","doi-asserted-by":"crossref","first-page":"e24557","DOI":"10.1097\/MD.0000000000024557","article-title":"Association of non-alcoholic fatty liver disease and all-cause mortality in hospitalized cardiovascular disease patients: a systematic review and meta-analysis.","volume":"100","author":"Saokaew","year":"2021","journal-title":"Medicine (Baltim)"},{"key":"R15-20260605","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10354-022-00914-5","article-title":"Chest CT severity score: assessment of COVID\u201119 severity and short-term prognosis in hospitalized Iranian patients.","volume":"172","author":"Aziz-Ahari","year":"2022","journal-title":"Wien Med Wochenschr"},{"key":"R16-20260605","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1148\/radiol.2020200370","article-title":"Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19).","volume":"295","author":"Pan","year":"2020","journal-title":"Radiology"},{"key":"R17-20260605","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1751-2980.2008.00331.x","article-title":"Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases.","volume":"9","author":"Zeng","year":"2008","journal-title":"J Dig Dis"},{"issue":"suppl_1","key":"R18-20260605","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/jcag\/gwy008.202","article-title":"A201 prevalence of nonalcoholic fatty liver disease in a cohort of healthy children in Ontario.","volume":"1","author":"Dhaliwal","year":"2018","journal-title":"J. Can. Assoc. Gastroenterol"},{"key":"R19-20260605","first-page":"425","article-title":"Analysis of fatty liver by CT values in obese children.","volume":"50","author":"Naganuma","year":"1996","journal-title":"Iryo (Medical Treatment)"},{"key":"R20-20260605","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/j.gastro.2016.03.009","article-title":"Comparison of the phenotype and approach to pediatric vs adult patients with nonalcoholic fatty liver disease.","volume":"150","author":"Nobili","year":"2016","journal-title":"Gastroenterology"},{"key":"R21-20260605","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s41747-021-00250-0","article-title":"Advances in liver US, CT, and MRI: moving toward the future.","volume":"5","author":"Vernuccio","year":"2021","journal-title":"Eur Radiol Exp"},{"key":"R22-20260605","doi-asserted-by":"crossref","first-page":"e0140908","DOI":"10.1371\/journal.pone.0140908","article-title":"The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis.","volume":"10","author":"Anderson","year":"2015","journal-title":"PLoS One"},{"key":"R23-20260605","doi-asserted-by":"crossref","first-page":"e00335","DOI":"10.1002\/edm2.335","article-title":"Adipose tissue measurement in clinical research for obesity, type 2 diabetes and NAFLD\/NASH.","volume":"5","author":"Vilalta","year":"2022","journal-title":"Endocrinol Diabetes Metab"},{"key":"R24-20260605","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/db14-0744","article-title":"Evidence of early alterations in adipose tissue biology and function and its association with obesity-related inflammation and insulin resistance in children.","volume":"64","author":"Landgraf","year":"2015","journal-title":"Diabetes"},{"key":"R25-20260605","first-page":"742","article-title":"High-sensitivity C-reactive protein relationship with metabolic disorders and cardiovascular diseases risk factors.","volume":"11","author":"Koziarska-Ro\u015bciszewska","year":"2021","journal-title":"Life (Basel)"},{"key":"R26-20260605","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.3390\/biomedicines11102711","article-title":"The potential role of C-reactive protein in metabolic-dysfunction-associated fatty liver disease and aging.","volume":"11","author":"Ding","year":"2023","journal-title":"Biomedicines"},{"key":"R27-20260605","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.3748\/wjg.v27.i22.3064","article-title":"COVID-19 and pediatric fatty liver disease: is there interplay?","volume":"27","author":"Di Sessa","year":"2021","journal-title":"World J Gastroenterol"},{"key":"R28-20260605","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.3390\/ijms23169196","article-title":"mTOR: a potential new target in nonalcoholic fatty liver disease.","volume":"23","author":"Feng","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R29-20260605","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/biom12060824","article-title":"NAFLD: mechanisms, treatments, and biomarkers.","volume":"12","author":"Nassir","year":"2022","journal-title":"Biomolecules"},{"key":"R30-20260605","first-page":"36","article-title":"The impact of nonalcoholic fatty liver disease on severe community-acquired pneumonia outcomes.","volume":"13","author":"Gjura\u0161in","year":"2022","journal-title":"Life (Basel)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:28:15Z","timestamp":1785940095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":29,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048414","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"2026-02-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}